Since December 2019, the rapid spread of COVID-19 corona-viruses worldwide has caused more than 7 million infections and more than 400,000 deaths. The rapid spread of COVID-19 demonstrates the dire need for quick and effective drug discovery. Drug repurposing is a drug discovery paradigm that uses existing drugs for new therapeutic indications. It has the advantages of significantly reducing time and cost relative to de novo drug discovery. Drug repurposing with knowledge graphs presents a promising strategy for COVID-19 treatment.
This is a companion discussion topic for the original entry at https://www.dgl.ai/news/2020/06/09/covid.html